Literature DB >> 22451766

Systemic antifungal drugs: Are we making any progress?

M Laverdière1.   

Abstract

Year:  1994        PMID： 22451766      PMCID： PMC3307410          DOI： 10.1155/1994/828061

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  19 in total

1.  Treatment of systemic fungal infections with liposomal amphotericin B.

Authors:  G Lopez-Berestein; G P Bodey; V Fainstein; M Keating; L S Frankel; B Zeluff; L Gentry; K Mehta
Journal:  Arch Intern Med       Date:  1989-11

2.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

3.  Treatment of invasive aspergillosis with itraconazole.

Authors:  D W Denning; R M Tucker; L H Hanson; D A Stevens
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

4.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Effects of ranitidine and sucralfate on ketoconazole bioavailability.

Authors:  S C Piscitelli; T F Goss; J H Wilton; D T D'Andrea; H Goldstein; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

6.  Drug interactions with fluconazole.

Authors:  J D Lazar; K D Wilner
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

Review 7.  Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.

Authors:  P Francis; T J Walsh
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

8.  Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.

Authors:  E Anaissie; G P Bodey; H Kantarjian; C David; K Barnett; E Bow; R Defelice; N Downs; T File; G Karam
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

9.  Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.

Authors:  D Caillot; O Casasnovas; E Solary; P Chavanet; B Bonnotte; G Reny; F Entezam; J Lopez; A Bonnin; H Guy
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

10.  Serum levels of ketoconazole in bone marrow transplanted patients.

Authors:  H Vu Van; M A Piens; E Archimbaud; M F Monier; D Guyotat; M Mojon; D Fiere
Journal:  Nouv Rev Fr Hematol       Date:  1983
View more
  1 in total

Review 1.  Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?

Authors:  Pedro Henrique França Gois; Daniela Ferreira; Simon Olenski; Antonio Carlos Seguro
Journal:  Nutrients       Date:  2017-06-24       Impact factor: 5.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.